Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period

Emphysema

Long-term Follow-up Results of Patients with Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience

Respir Med

Calis AG, Uzer F, Gurbuz AF, Ozbey G, Cilli A

doi: 10.1016/j.rmed.2026.108780

RECOMMENDED

Pulmonary Hypertension

Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension

★ 3 Recommended by Dr Martin Frey, Faculty Member

Chest

Szwed P, Kurzyna P, Banaszkiewicz-Cyganik M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S

doi: 10.1016/j.chest.2025.10.017

Pulmonary Hypertension

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model

Adv Ther

Alsumali A, McLaughlin V, Chevure J, Klok R, Zhang W, Martinez EC, Pausch C, De Oliveira Pena J, van de Wetering G, Jootun M, Lautsch D, Hoeper MM

doi: 10.1007/s12325-025-03241-4

RECOMMENDED

Pulmonary Hypertension

Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries

★ 2 Recommended by Dr Martin Frey, Faculty Member

J Clin Med

Hirono K, Uchida K, Ishii T, Ishida H, Takatsuki S, Fukushima H, Inai K, Hosokawa S, Ishizaki R, Sawada H, Sumitomo NF, Chida-Nagai A, Ishikawa Y, Motoki H, Yao A, Kogaki S, Yamagishi H, Doi S

doi: 10.3390/jcm15031087

RECOMMENDED

Further Publications

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension Study

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Daines CL, Polineni D, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Quon BS, Ringshausen FC, Selvadurai H, Taylor-Cousar JL, Withers NJ, Sawicki GS, Lee T, Ahluwalia N, Morlando Geiger J, Jennings M, Tan YV, Waltz D, Ramsey B, Griese M, VX17-445-105 Study Group

doi: 10.1164/rccm.202411-2231OC

RECOMMENDED

Cough

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension

★ 1 Recommended by Dr Martin Frey, Faculty Member

Am J Respir Crit Care Med

Hill NS, Gillies H, Chakinala MM, Feldman JP, Hoeper MM, Jing ZC, McLaughlin VV, Rosenkranz S, Escribano-Subias P, Ghio S, Gomberg-Maitland M, Habib N, Kopec G, Langleben D, Lescano A, Ramirez A, Rischard F, Sitbon O, Skride A, Dake BT, Khindri S, Langley J, Niven R, Zhang X, Humbert M, IMPAHCT Investigators

doi: 10.1093/ajrccm/aamaf128

Pulmonary Hypertension

A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension

Respir Med

Paoli CJ, Zhang C, Tang X, Panjabi S, Thompson A, El-Kersh K

doi: 10.1016/j.rmed.2025.108112

Lung Cancer

A Phase II Study of Accelerated Hyperfractionated Thoracic Radiotherapy With Dose Escalation to 54 Gy With Concurrent Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution

Clin Lung Cancer

Matsuura K, Komaki R, Kono M, Kudo T, Ono A, Kameoka T, Shintani I, Kusaba H, Kawakubo A, Ando Y, Nishihara K, Iwamoto Y, Shoda H, Katsuta T, Kagemoto M

doi: 10.1016/j.cllc.2025.09.003

Pulmonary Fibrosis

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: Results from an open-label extension study

Ann Am Thorac Soc

Chmiel JF, McBennett K, Quon BS, Colombo C, De Wachter E, Fajac I, Mondejar-Lopez P, Polineni D, Robinson P, Sutharsan S, Mall MA, McKone EF, Ramsey B, Taylor-Cousar JL, Tullis E, Suresh NE, Zhang Y, Sosnay P, Jennings M, Barry PJ, 445-110 study group

doi: 10.1093/annalsats/aaoag053

Related content

Long-term Follow-up Results of Patients with Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience

Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model

Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Extension Study

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension

A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension

A Phase II Study of Accelerated Hyperfractionated Thoracic Radiotherapy With Dose Escalation to 54 Gy With Concurrent Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: Results from an open-label extension study